Search research articles
Contact Us
Filters
Showing results (1111-1120 of 1,297) with videos related to
Page
of 130
Sort By:
Biomarkers in Medicine
|
July 26, 2018
Inflammatory biomarker in adipose stem cells of women with endometrial cancer
Faina Linkov, Sharon L Goughnour, Shalkar Adambekov, et al.
The Prostate
|
June 9, 2016
The Germ Cell Gene TDRD1 as an ERG Target Gene and a Novel Prostate Cancer Biomarker
Lijuan Xiao, Rainer B Lanz, Anna Frolov, et al.
Cancer Research
|
November 8, 2018
Mammary Precancerous Stem and Non-Stem Cells Evolve into Cancers of Distinct Subtypes
Wen Bu, Zhenyu Liu, Weiyu Jiang, et al.
Eneuro
|
September 29, 2017
The Progestin Receptor Interactome in the Female Mouse Hypothalamus: Interactions with Synaptic Proteins Are Isoform Specific and Ligand Dependent
Kalpana D Acharya, Sabin A Nettles, Katherine J Sellers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 31, 2013
Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer
Swati Suryawanshi, Anda M Vlad, Hui-Min Lin, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 5, 1999
Nonsteroidal progesterone receptor antagonists based on a conformationally-restricted subseries of 6-aryl-1,2-dihydro-2,2,4-trimethylquinolines
L G Hamann, D T Winn, C L Pooley, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 27, 2020
Discovery and optimization of new oxadiazole substituted thiazole RORγt inverse agonists through a bioisosteric amide replacement approach
Christoph Steeneck, Christian Gege, Olaf Kinzel, et al.
Endocrine-Related Cancer
|
January 29, 2019
UCHL1 loss alters the cell-cycle in metastatic pancreatic neuroendocrine tumors
Brendan M Finnerty, Maureen D Moore, Akanksha Verma, et al.
Oncoimmunology
|
October 6, 2018
TGF-β1 programmed myeloid-derived suppressor cells (MDSC) acquire immune-stimulating and tumor killing activity capable of rejecting established tumors in combination with radiotherapy
Padmini Jayaraman, Falguni Parikh, Jared M Newton, et al.
Journal of Medicinal Chemistry
|
December 12, 2024
Toward Dose Prediction at Point of Design
Dries Van Rompaey, Siladitya Ray Chaudhuri, Mazen Ahmad, et al.
Page
of 130
Search research articles
Search
Showing results (1111-1120 of 1,297) with videos related to
Sort By:
Page
of 130
Biomarkers in Medicine
|
July 26, 2018
Inflammatory biomarker in adipose stem cells of women with endometrial cancer
Faina Linkov, Sharon L Goughnour, Shalkar Adambekov, et al.
The Prostate
|
June 9, 2016
The Germ Cell Gene TDRD1 as an ERG Target Gene and a Novel Prostate Cancer Biomarker
Lijuan Xiao, Rainer B Lanz, Anna Frolov, et al.
Cancer Research
|
November 8, 2018
Mammary Precancerous Stem and Non-Stem Cells Evolve into Cancers of Distinct Subtypes
Wen Bu, Zhenyu Liu, Weiyu Jiang, et al.
Eneuro
|
September 29, 2017
The Progestin Receptor Interactome in the Female Mouse Hypothalamus: Interactions with Synaptic Proteins Are Isoform Specific and Ligand Dependent
Kalpana D Acharya, Sabin A Nettles, Katherine J Sellers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 31, 2013
Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer
Swati Suryawanshi, Anda M Vlad, Hui-Min Lin, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 5, 1999
Nonsteroidal progesterone receptor antagonists based on a conformationally-restricted subseries of 6-aryl-1,2-dihydro-2,2,4-trimethylquinolines
L G Hamann, D T Winn, C L Pooley, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 27, 2020
Discovery and optimization of new oxadiazole substituted thiazole RORγt inverse agonists through a bioisosteric amide replacement approach
Christoph Steeneck, Christian Gege, Olaf Kinzel, et al.
Endocrine-Related Cancer
|
January 29, 2019
UCHL1 loss alters the cell-cycle in metastatic pancreatic neuroendocrine tumors
Brendan M Finnerty, Maureen D Moore, Akanksha Verma, et al.
Oncoimmunology
|
October 6, 2018
TGF-β1 programmed myeloid-derived suppressor cells (MDSC) acquire immune-stimulating and tumor killing activity capable of rejecting established tumors in combination with radiotherapy
Padmini Jayaraman, Falguni Parikh, Jared M Newton, et al.
Journal of Medicinal Chemistry
|
December 12, 2024
Toward Dose Prediction at Point of Design
Dries Van Rompaey, Siladitya Ray Chaudhuri, Mazen Ahmad, et al.
Page
of 130